000			02060cam a2200265 4500
100	1		_aAYA Ekshtein
700			_aGAL Hay
700			_aSHACHAR Shapira
700			_aODED Ben-Ari
245			_aReturn to flying duties following a COVID-19 booster dose/ _cEkshtein, Aya; Hay, Gal; Shapira, Shachar; Ben-Ari, Oded
260			_c2022
520			_aINTRODUCTION: Israel began vaccinating with the booster dose of the Pfizer-BioNTech vaccine in July 2021, before the Food and Drug Administration (FDA) authorized the vaccine in September 2021. The first and second vaccines were shown to have several side effects that could possibly affect aircrews' fitness to fly. Thus, the Israel Air Force (IAF) decided on a disqualification period of 24 h following the first vaccine, and 48 h following the second vaccine. The aim of this study was to determine the disqualification period following the booster dose of the vaccine.
520			_aMETHODS: A survey was conducted among IAF aviators in the Aeromedical Center (AMC) in order to characterize the side effects and their duration following a Pfizer-BioNTech COVID-19 vaccine booster dose.
520			_aRESULTS: The most common local side effect was injection site pain. The most common systemic side effects were general weakness, fatigue, and myalgia. Duration of side effects was up to 48 h from vaccine administration among the majority of aircrew members.
520			_aCONCLUSION: The IAF AMC policy for the Pfizer-BioNTech COVID-19 vaccine booster dose recipients is to disqualify from flight for 48 h following the vaccination.
650			_aCOVID-19 VACCINE _xCORONAVIRUS DISEASE 2019
650			_aAIRCREW
650			_aBOOSTER DOSE; SIDE EFFECTS
650			_aDISQUALIFICATION PERIOD
650			_aHEALTH
773			_aAerospace Medicine and Human Performance: _gVol 93, No. 7, July 2022, pp. 593-596 (62)
598			_aCOVID-19, HEALTH
856			_uhttps://www.ingentaconnect.com/contentone/asma/amhp/2022/00000093/00000007/art00009 _zClick here for more
945			_i67740.1001 _rY _sY
999			_c41742 _d41742